Oxymetholone
Spezifikationen
434-07-1CAS-Nummer
207-098-6EG-Nummer
(2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-oneIUPAC-Name
C21H32O3Chemische Formel
332.5 g/molMolekulargewicht
oxymetholone; 434-07-1; Anasteron; Protanabol; Anapolon; Nastenon; Adroyd; Anadrol; Anadrol-50; Oxymethenolone; Oximetolona; Plenastril; Synasteron; Roboral; Oxymethalone; Adroidin; Becorel; Dynasten; Pardroyd; Pavisoid; Zenalosyn; Oximetholonum; Oxymetholonum; Anadroyd; Anasteronal; Methabol; Oximetalonu; CI-406; Oxitosona-50; Ossimetolone; Oxymetholone ciii; DTXSID5023794; NSC-26,198; L76T0ZCA8K; 17-Hydroxy-5-alpha-androstan-3-one; CI 406; NSC-26198; 2-Hydroxymethylene-17alpha-methyldihydrotestosterone; 4,5alpha-Dihydro-2-hydroxymethylene-17alpha-methyltestosterone; 2-Hydroxymethylene-17alpha-methyl-5alpha-androstan-17beta-ol-3-one; 17alpha-Methyl-2-hydroxymethylene-17-hydroxy-5alpha-androstan-3-one; 17-Hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-17-beta-androst-3-one; 2-Hydroxymethylene-17alpha-methyl-17beta-hydroxy-5alpha-androstan-3-one; 2-Hydroxymethylene-17-alpha-methyl-dihydrotestosterone; CHEBI:7864; DTXCID003794; 2-Hydroxymethylene-17alpha-methylandrostan-17beta-ol-3-one; 4,5-Dihydro-2-hydroxymethylene-17-alpha-methyltestosterone; 17-beta-Hydroxy-2-hydroxymethylene-17-alpha-methyl-3-androstanone; 17-alpha-Methyl-2-hydroxymethylene-17-hydroxy-5-alpha-androstan-3-one; 2-Hydroxymethylene-17-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one; 5alpha-Androstan-3-one, 17beta-hydroxy-2-(hydroxymethylene)-17-methyl-; 17-beta-Hydroxy-2-(hydroxymethylene)-17-alpha-methyl-5-alpha-androstan-3-one; Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5alpha,17beta)-; Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (alpha,17beta)-; Hydroxymetholone; 5-alpha-Androstan-3-one, 17-beta-hydroxy-2-(hydroxymethylene)-17-methyl-; Androstano(2,3-c)(1,2,5)oxadiazol-17-ol, 17-methyl-, (5-alpha,17-beta)-; (2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one; Hemogenin; Oxitosona; (2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-3-one; RefChem:55795; 2-(HYDROXYMETHYLENE)-17-METHYLDIHYDROTESTOSTERONE; CL-406; 17beta-Hydroxy-2-hydroxymethylene-17alpha-methyl-5alpha-androstan-3-one; 207-098-6; NSC93895; Anasterone; Oximetholone; HMD; NIOSH/BV8059400; NCGC00091430-01; BV80594000; Anapolon 50; Ossimetolone [DCIT]; 2-Hydroxymethyleneandrostan-17-beta-ol-17-alpha-methyl-3-one; Androstan-3-one, 17-beta-hydroxy-2-(hydroxymethylene)-17-alpha-methyl-; Oxymetholone (1mg/ml in Acetonitrile); Oximetolona [INN-Spanish]; Oxymetholonum [INN-Latin]; CAS-434-07-1; CCRIS 492; HSDB 3374; EINECS 207-098-6; UNII-L76T0ZCA8K; Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5.alpha.,17.beta.)-; ICMWWNHDUZJFDW-DHODBPELSA-N; Anadrol-50 (TN); Oxymetholone [USAN:USP:INN:BAN:JAN]; 2-Hydroxymethylene-17alpha-methyl-17beta-hydroxy-3-adrostanone; 2-Hydroxymethylene-17-alpha-methyl-17-beta-hydroxy-3-androstanone; OXYMETHOLONE [MI]; Stanozolol EP Impurity B; OXYMETHOLONE [INN]; OXYMETHOLONE [JAN]; Stanozolol impurity B CRS; OXYMETHOLONE [HSDB]; OXYMETHOLONE [USAN]; OXYMETHOLONE [VANDF]; OXYMETHOLONE [MART.]; OXYMETHOLONE [WHO-DD]; SCHEMBL145158; CHEMBL1200585; CHEMBL1578149; Oxymetholone (JP17/USP/INN); GLXC-04661; OXYMETHOLONE [ORANGE BOOK]; OXYMETHOLONE CIII [USP-RS]; (2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one; OXYMETHOLONE [USP MONOGRAPH]; Tox21_111131; Tox21_200071; BDBM50248303; MFCD00869395; Oxymetholone, 1mg/ml in Acetonitrile; 5-alpha,17-beta-Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-; AKOS027473312; MSK8563-1000A; Tox21_111131_1; DB06412; Androstan-3-one, 17-hydroxy-2-(hydroxymethylene)-17-methyl-, (5-alpha,17-beta)-; Oxymetholone (1 mg/ml in Acetonitrile); NCGC00091430-02; NCGC00257625-01; NCGC00263581-01; (5S,8R,9S,10S,13S,14S,17S,Z)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; FO156787; NS-05498; STANOZOLOL IMPURITY B [EP IMPURITY]; NS00020649; C07393; D00490; AB01566927_01; Oxymetholone Solution in Acetonitrile, 1000ug/mL; Q420864; 17-Hydroxy-2-(hydroxymethylene)-17-methyl-5-androstan-3-one; 17beta-Hydroxy-2-hydroxymethylidene-17alpha-methyl-3-androstanone; 17alpha-Methyl-2-hydroxymethylene-17beta-hydroxy-5alpha-androstan-3-one; 17beta-hydroxy-2-(hydroxymethylidene)-17-methyl-5alpha-androstan-3-one; (2Z)-17beta-Hydroxy-2-(hydroxymethylidene)-17alpha-methyl-5alpha-androstan-3-one; (5alpha,17beta)-17-hydroxy-2-(hydroxymethylidene)-17-methylandrostan-3-one; (1S,3aS,3bR,5aS,8Z,9aS,9bS,11aS)-1-hydroxy-8-(hydroxymethylidene)-1,9a,11a-trimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-7-one; (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylene)-10,13,17-trimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; ANDROSTAN-3-ONE, 17-HYDROXY-2-(HYDROXYMETHYLENE)-17-METHYL-, (2Z,5.ALPHA.,17.BETA.)-Synonyme
